About this trial
Both Baylor St Luke's Medical Center and Mayo Scottsdale are considered endoscopic submucosal dissection (ESD) centers of excellence. The investigators at Baylor College of Medicine have previously reported our Esophageal ESD experience using the monopolar current knife. Moreover, the research team have previously reported on the clinical efficacy of the bipolar RFA knife during per-oral endoscopic myotomy (POEM) and colonic ESD. The goal of our study is to prospectively evaluate the efficacy, safety and feasibility of Esophageal ESD using a novel Bipolar-Current ESD device.
Eligibility criteria
Qualifiers
Patient is >18 years of age
Patient can provide informed consent
Mucosal based polyp
Located gastroesophageal junction (GEJ) or proximal to GEJ
Disqualifiers
Patients with International Normalized Ratio (INR) >1.5 or Platelets <50,000
Lesions extending past GEJ
Subepithelial lesions
Trial design
Treatments tested in this trial
- Speedboat™ Ultraslim
Treatment groups
Sponsors and collaborators
Baylor College of Medicine
Lead sponsor
Creo Medical Limited
Collaborator